Logo image of APO

APOLLO GLOBAL MANAGEMENT INC (APO) Stock Fundamental Analysis

NYSE:APO - New York Stock Exchange, Inc. - US03769M1062 - Common Stock

169.24  +2.25 (+1.35%)

Premarket: 169.56 +0.32 (+0.19%)

Fundamental Rating

4

Taking everything into account, APO scores 4 out of 10 in our fundamental rating. APO was compared to 101 industry peers in the Financial Services industry. APO has a medium profitability rating, but doesn't score so well on its financial health evaluation. APO is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year APO was profitable.
APO had a positive operating cash flow in the past year.
APO had positive earnings in 4 of the past 5 years.
APO had a positive operating cash flow in 4 of the past 5 years.
APO Yearly Net Income VS EBIT VS OCF VS FCFAPO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B -4B 6B

1.2 Ratios

APO has a Return On Assets of 1.51%. This is comparable to the rest of the industry: APO outperforms 47.52% of its industry peers.
APO has a Return On Equity of 31.13%. This is amongst the best in the industry. APO outperforms 91.09% of its industry peers.
APO's Return On Invested Capital of 1.92% is in line compared to the rest of the industry. APO outperforms 46.53% of its industry peers.
Industry RankSector Rank
ROA 1.51%
ROE 31.13%
ROIC 1.92%
ROA(3y)2.06%
ROA(5y)3.23%
ROE(3y)10.97%
ROE(5y)16.97%
ROIC(3y)N/A
ROIC(5y)N/A
APO Yearly ROA, ROE, ROICAPO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40

1.3 Margins

APO has a better Profit Margin (18.74%) than 70.30% of its industry peers.
APO's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 29.35%, APO is in the better half of the industry, outperforming 73.27% of the companies in the same industry.
APO's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 29.35%
PM (TTM) 18.74%
GM N/A
OM growth 3Y-20.74%
OM growth 5Y-2.99%
PM growth 3Y46.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APO Yearly Profit, Operating, Gross MarginsAPO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so APO is destroying value.
APO has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, APO has more shares outstanding
The debt/assets ratio for APO is higher compared to a year ago.
APO Yearly Shares OutstandingAPO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M 500M
APO Yearly Total Debt VS Total AssetsAPO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100B 200B 300B

2.2 Solvency

APO has an Altman-Z score of 0.31. This is a bad value and indicates that APO is not financially healthy and even has some risk of bankruptcy.
APO's Altman-Z score of 0.31 is in line compared to the rest of the industry. APO outperforms 44.55% of its industry peers.
APO has a debt to FCF ratio of 2.14. This is a good value and a sign of high solvency as APO would need 2.14 years to pay back of all of its debts.
APO has a Debt to FCF ratio of 2.14. This is in the better half of the industry: APO outperforms 70.30% of its industry peers.
APO has a Debt/Equity ratio of 0.64. This is a neutral value indicating APO is somewhat dependend on debt financing.
APO has a Debt to Equity ratio of 0.64. This is comparable to the rest of the industry: APO outperforms 51.49% of its industry peers.
Although APO does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.14
Altman-Z 0.31
ROIC/WACC0.21
WACC9.01%
APO Yearly LT Debt VS Equity VS FCFAPO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B 10B

2.3 Liquidity

A Current Ratio of 0.06 indicates that APO may have some problems paying its short term obligations.
The Current ratio of APO (0.06) is worse than 81.19% of its industry peers.
APO has a Quick Ratio of 0.06. This is a bad value and indicates that APO is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.06, APO is doing worse than 81.19% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
APO Yearly Current Assets VS Current LiabilitesAPO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B 10B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.92% over the past year.
APO shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 49.43% yearly.
APO shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.12%.
APO shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 94.91% yearly.
EPS 1Y (TTM)13.92%
EPS 3Y49.43%
EPS 5YN/A
EPS Q2Q%8.19%
Revenue 1Y (TTM)21.12%
Revenue growth 3Y134.55%
Revenue growth 5Y94.91%
Sales Q2Q%199.54%

3.2 Future

The Earnings Per Share is expected to grow by 16.14% on average over the next years. This is quite good.
APO is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -11.56% yearly.
EPS Next Y6.84%
EPS Next 2Y13.14%
EPS Next 3Y14.86%
EPS Next 5Y16.14%
Revenue Next Year20.69%
Revenue Next 2Y18.84%
Revenue Next 3Y18.01%
Revenue Next 5Y-11.56%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
APO Yearly Revenue VS EstimatesAPO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 10B 20B 30B
APO Yearly EPS VS EstimatesAPO Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 2 4 6 8 10

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.77, the valuation of APO can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of APO is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 28.29. APO is around the same levels.
The Price/Forward Earnings ratio is 19.62, which indicates a rather expensive current valuation of APO.
61.39% of the companies in the same industry are cheaper than APO, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 24.44. APO is around the same levels.
Industry RankSector Rank
PE 23.77
Fwd PE 19.62
APO Price Earnings VS Forward Price EarningsAPO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, APO is valued a bit cheaper than 76.24% of the companies in the same industry.
66.34% of the companies in the same industry are more expensive than APO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 18
EV/EBITDA 9.32
APO Per share dataAPO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as APO's earnings are expected to grow with 14.86% in the coming years.
PEG (NY)3.47
PEG (5Y)N/A
EPS Next 2Y13.14%
EPS Next 3Y14.86%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.11%, APO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.66, APO pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.28, APO's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of APO decreases each year by -3.87%.
APO has been paying a dividend for at least 10 years, so it has a reliable track record.
APO has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.87%
Div Incr Years2
Div Non Decr Years2
APO Yearly Dividends per shareAPO Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0.5 1 1.5 2

5.3 Sustainability

APO pays out 21.02% of its income as dividend. This is a sustainable payout ratio.
DP21.02%
EPS Next 2Y13.14%
EPS Next 3Y14.86%
APO Yearly Income VS Free CF VS DividendAPO Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 2B -2B 4B 6B
APO Dividend Payout.APO Dividend Payout, showing the Payout Ratio.APO Dividend Payout.PayoutRetained Earnings

APOLLO GLOBAL MANAGEMENT INC

NYSE:APO (1/21/2025, 8:04:00 PM)

Premarket: 169.56 +0.32 (+0.19%)

169.24

+2.25 (+1.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-04 2025-02-04/amc
Inst Owners62.18%
Inst Owner Change0%
Ins Owners2.39%
Ins Owner Change-0.53%
Market Cap95.76B
Analysts79.2
Price Target184.8 (9.19%)
Short Float %8.86%
Short Ratio6.07
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend1.82
Dividend Growth(5Y)-3.87%
DP21.02%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.7%
Min EPS beat(2)-7.59%
Max EPS beat(2)6.2%
EPS beat(4)2
Avg EPS beat(4)1%
Min EPS beat(4)-7.59%
Max EPS beat(4)9.67%
EPS beat(8)3
Avg EPS beat(8)-1.07%
EPS beat(12)5
Avg EPS beat(12)0.65%
EPS beat(16)9
Avg EPS beat(16)11.09%
Revenue beat(2)2
Avg Revenue beat(2)70%
Min Revenue beat(2)53.68%
Max Revenue beat(2)86.31%
Revenue beat(4)4
Avg Revenue beat(4)106.03%
Min Revenue beat(4)53.68%
Max Revenue beat(4)202.3%
Revenue beat(8)7
Avg Revenue beat(8)113.02%
Revenue beat(12)10
Avg Revenue beat(12)104.56%
Revenue beat(16)14
Avg Revenue beat(16)108.57%
PT rev (1m)6.76%
PT rev (3m)42.1%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.08%
EPS NY rev (1m)0%
EPS NY rev (3m)1.43%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.41%
Valuation
Industry RankSector Rank
PE 23.77
Fwd PE 19.62
P/S 3.23
P/FCF 18
P/OCF 18
P/B 5.36
P/tB 7.08
EV/EBITDA 9.32
EPS(TTM)7.12
EY4.21%
EPS(NY)8.63
Fwd EY5.1%
FCF(TTM)9.4
FCFY5.56%
OCF(TTM)9.4
OCFY5.56%
SpS52.46
BVpS31.57
TBVpS23.91
PEG (NY)3.47
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.51%
ROE 31.13%
ROCE 2.43%
ROIC 1.92%
ROICexc 2.01%
ROICexgc 2.24%
OM 29.35%
PM (TTM) 18.74%
GM N/A
FCFM 17.93%
ROA(3y)2.06%
ROA(5y)3.23%
ROE(3y)10.97%
ROE(5y)16.97%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y-22.92%
ROICexcg growth 5Y-17.56%
ROICexc growth 3Y-24.72%
ROICexc growth 5Y-18.5%
OM growth 3Y-20.74%
OM growth 5Y-2.99%
PM growth 3Y46.16%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.08
Health
Industry RankSector Rank
Debt/Equity 0.64
Debt/FCF 2.14
Debt/EBITDA 1.17
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 10.92
Cash Conversion 54.81%
Profit Quality 95.68%
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z 0.31
F-Score6
WACC9.01%
ROIC/WACC0.21
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.92%
EPS 3Y49.43%
EPS 5YN/A
EPS Q2Q%8.19%
EPS Next Y6.84%
EPS Next 2Y13.14%
EPS Next 3Y14.86%
EPS Next 5Y16.14%
Revenue 1Y (TTM)21.12%
Revenue growth 3Y134.55%
Revenue growth 5Y94.91%
Sales Q2Q%199.54%
Revenue Next Year20.69%
Revenue Next 2Y18.84%
Revenue Next 3Y18.01%
Revenue Next 5Y-11.56%
EBIT growth 1Y81.84%
EBIT growth 3Y85.9%
EBIT growth 5Y89.08%
EBIT Next Year20.27%
EBIT Next 3Y15.05%
EBIT Next 5YN/A
FCF growth 1Y338.29%
FCF growth 3YN/A
FCF growth 5Y51.22%
OCF growth 1Y325.32%
OCF growth 3YN/A
OCF growth 5Y50.67%